Invasive zygomycosis in India: Experience in a tertiary care hospital

Postgraduate Medical Journal

Volumn 85, Issue 1009, 2009, Pages 573-581

  Chakrabarti, A ^a   Chatterjee, S S ^a   Das, A ^a   Panda, N ^a   Shivaprakash, M R ^a   Kaur, A ^a   Varma, S C ^a   Singhi, S ^a   Bhansali, A ^a   Sakhuja, V ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; AMPHOTERICIN B DEOXYCHOLATE; AMPHOTERICIN B LIPID COMPLEX; FLUCONAZOLE; GRANULOCYTE COLONY STIMULATING FACTOR; STEROID;

ADOLESCENT; ADULT; AGED; ANATOMICAL VARIATION; APOPHYSOMYCES ELEGANS; ARTICLE; AUTOPSY; BRAIN INFECTION; CANDIDIASIS; CHILD; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DEBRIDEMENT; DERMATOMYCOSIS; DIABETIC KETOACIDOSIS; DISEASE COURSE; DISEASE REGISTRY; DRUG DOSE REDUCTION; FUNGUS ISOLATION; GASTROINTESTINAL INFECTION; HISTORY OF MEDICINE; HOSPITAL INFECTION; HUMAN; INDIA; INFANT; INFECTION RISK; KIDNEY FAILURE; KIDNEY INFECTION; LUNG MYCOSIS; MORTALITY; MUCORMYCOSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; NOSE INFECTION; ORBIT INFECTION; OUTCOME ASSESSMENT; PRESCHOOL CHILD; PROGNOSIS; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; RHIZOPUS ORYZAE; SCHOOL CHILD; TERTIARY HEALTH CARE; ZYGOMYCETES;

ADOLESCENT; ADULT; AGED; ANTIFUNGAL AGENTS; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INDIA; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; MUCORALES; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; YOUNG ADULT; ZYGOMYCOSIS;

EID: 73249149842     PISSN: 00325473     EISSN: 14690756     Source Type: Journal    
DOI: 10.1136/pgmj.2008.076463     Document Type: Article

References (35)

1. Ribes JA, Vanover-Sams CL, Baker DJ. Zygomycetes in human disease. Clin Microbiol Rev 2000;13:236-301.
2. Roden MM, Zaoutrs TE, Buchanan WL, et al. Epidemiology and outcome of zygomycosis: a review of 929 reported cases. Clin Infect Dis 2005;41:634-53.
3. Spellberg B, Edwards J Jr, Ibrahim A. Novel perspectives on mucormycosis: pathophysiology, presentation and management. Clin Microbiol Rev 2005;18:556-69.
4. Chakrabarti A, Das A, Mandal J, et al. The rising trend of invasive zygomycosis in patients with uncontrolled diabetes mellitus. Med Mycol 2006;44:335-42.
5. Kauffman CA. Zygomycosis: reemergence of an old pathogen. Clin Infect Dis 2004;39:588-90.
6. Chakrabarti A, Das A, Sharma A, et al. Ten years' experience in zygomycosis at a tertiary care centre in India. J Infect 2001;42:261-6.
7. Kontoyiannis DP, Wessel VC, Bodey GP, et al. Zygomycosis in the 1990s in a tertiary care cancer center. Clin Infect Dis 2000;30:851-6.
8. Marr KA, Carter RA, Crippa F, et al. Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients. Clin Infect Dis 2002;34:909-17.
9. Teasdale G, Jennett B. Assessment and prognosis of coma after head injury. Acta Neurochir 1976;34:45-55.
10. Nussbaum ES, Hall WA. Rhinocerebral mucormycosis: changing patterns of disease. Surg Neurol 1994;41:152-6.
11. Trof RJ, Beishuizen A, Debets-Ossenkopp YJ, et al. Management of invasive pulmonary aspergillosis in non-neutropenic critically ill patients. Intensive Care Med 2007;33:1694-703.
12. Meersseman W, Lagrou K, Maertens J, et al. Invasive aspergillosis in the intensive care unit. Clin Infect Dis 2007;45:205-16.
13. Nithyanandam S, Jacob MS, Battu RR, et al. Rhino-orbito-cerebral mucormycosis. A retrospective analysis of clinical features and treatment outcomes. Indian J Ophthal 2003;51:231-6.
14. Morrison VA, McGlave PB. Mucormycosis in BMT population. Bone Marrow Transplant 1993;11:383-8.
15. Bigby TD, Serota ML, Tierny LM Jr, et al. Clinical spectrum of pulmonary mucormycosis. Chest 1986;89:435-9.
16. Tedder M, Spratt JA, Anstadt MP, et al. Pulmonary mucormycosis: results of medical and surgical therapy. Ann Thorac Surg 1994;57:1044-50.
17. Pagano L, Ricci P, Nosari A, et al. Fatal haemoptysis in pulmonary filamentous mycosis: an underevaluated cause of death in patients with acute leukemia in hematological complete remission. A retrospective study and review of literature. Br J Haematol 1995;89:500-5.
18. Parfrey NA. Improved diagnosis and prognosis of mucormycosis: a clinicopatholgic study of 33 cases. Medicine 1986;65:113-23.
19. Gleissner B, Schilling A, Anagnostopolous I, et al. Improved outcome of zygomycosis in patients with hematological diseases? Leukemia Lymphoma 2004;45:1351-60.
20. Kline MW. Mucormycosis in children: review of literature and report of cases. Pediatr Infect Dis 1985;4:672-6.
21. Reimund E, Ramos A. Disseminated neonatal gastrointestinal mucormycosis: a case report and review of literature. Pediatr Pathol 1994;14:385-9.
22. ter Borg F, Kuijper EJ, van der Lelie H. Fatal mucormycosis presenting as an appendiceal mass with metastatic spread to the liver during chemotherapy-induced granulocytopenia. Scan J Infect Dis 1990;22:499-501.
23. Adam RD, Hunter G, DiTomasso J, et al. Mucormycosis: emerging prominence of cutaneous infections. Clin Infect Dis 1994;19:67-76.
24. Boyd AS, Wiser B, Sams HH, et al. Gangrenous cutaneous mucormycosis in a child with a solid organ transplant: a case report and review of literature. Pediatr Dermatol 2003;20:411-5.
25. Fatterpekar G, Mukhrerji S, Arbealez A, et al. Fungal diseases of the paranasal sinuses. Semin Ultrasound CT MR 1999;20:391-401.
26. Chakrabarti A, Ghosh A, Prasad GS, et al. Apophysomyces elegans: an emerging zygomycete in India. J Clin Microbiol 2003;41:783-8.
27. Kamalam A, Thambiah AS. Cutaneous infection by Syncephalastrum. Sabouraudia 1980;18:19-20.
28. Bottone EJ, Weitzman I, Hanna BA. Rhizopus rhizopodiformis: emerging etiological agent of mucormycosis. J Clin Microbiol 1979;9:530-7.
29. Misra PC, Srivastava KJ, Lata K. Apophysomyces, a new genus of the Mucorales. Mycotaxon 1979;8:377-82.
30. Menezes EA, Trindade EC, Costa MM, et al. Airborne fungi isolated from Fortaleza City, State Of Ceará, Brazil. Rev Inst Med Trop Sao Paulo 2004;46:133-7.
31. Zielińska-Jankiewicz K, Kozajda A, Piotrowska M, et al. Microbiological contamination with moulds in work environment in libraries and archive storage facilities. Ann Agric Environ Med 2008;15:71-8.
32. Codina R, Fox RW, Lockey RF, et al. Typical levels of airborne fungal spores in houses without obvious moisture problems during a rainy season in Florida, USA. J Investig Allergol Clin Immunol 2008;18:156-62.
33. Chakrabarti A, Nayak N, Kumar PS, et al. Surveillance of nosocomial fungal infections in a burn care unit. Infection 1992;20:132-5.
34. Thursky KA, Playford EG, Seymour JF, et al. Recommendations for the treatment of established fungal infections. Intern Med J 2008;38:496-520.
35. Petrikkos G, Skiada A, Sambatakou H, et al. Mucormycosis: ten-year experience at a tertiary care center in Greece. Eur J Clin Microbiol Infect Dis 2003;22:753-6.